Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
about
Survival of Patients with Primary Brain Tumors: Comparison of Two Statistical Approaches.Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma.Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy.Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.Novel therapies in glioblastoma.Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge.Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme.Innovative Hypofractionated Stereotactic Regimen Achieves Excellent Local Control with No Radiation Necrosis: Promising Results in the Management of Patients with Small Recurrent Inoperable GBMReirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort.Neural stem cell sparing by linac based intensity modulated stereotactic radiotherapy in intracranial tumorsRe-irradiation alternatives for recurrent high-grade glioma.Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.Reirradiation to the abdomen for gastrointestinal malignancies.Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local controlBevacizumab as a treatment option for radiation-induced cerebral necrosis.Long-term survival after gamma knife radiosurgery in a case of recurrent glioblastoma multiforme: a case report and review of the literature.Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG).The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigensRe-irradiation after gross total resection of recurrent glioblastoma : Spatial pattern of recurrence and a review of the literature as a basis for target volume definition.[Long-Term Relief of Cerebral Radiation Necrosis Treated with Low-Dose Bevacizumab - a Report of 2 Cases].The evolving role for re-irradiation in the management of recurrent grade 4 glioma.Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas.External beam radiotherapy of recurrent glioma: radiation tolerance of the human brain.MRI during radiotherapy of glioblastoma : Does MRI allow for prognostic stratification?Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma.Recurrent glioblastoma: who receives tumor specific treatment and how often?Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma: first tolerability and feasibility results.Radiation therapy for the treatment of recurrent glioblastoma: an overview.Hypofractionated stereotactic reirradiation for recurrent glioblastoma.Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institution.Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.Radiation treatment parameters for re-irradiation of malignant glioma.Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis.
P2860
Q30390268-A1D14AC1-87F7-45F3-886F-6ADC93F388DEQ33642508-E8473590-DD2C-4776-A474-765D43F783E7Q34136061-F8D08EB2-E833-49FF-A407-D181AE7EA001Q34812560-7B4E09FA-0990-4F08-AF20-AA911A107B40Q35676452-9A3F8132-52B2-417B-A88E-3D2D69692BBDQ35864136-33E467C8-62D2-40E9-8C9D-F8192B0F899DQ36482578-090F55F0-5234-46DF-8441-34CAE3F951D6Q36730160-4AB3E123-F551-4AA6-B97C-996BE2980F36Q36808220-C9F029CC-12B5-4886-8ABA-0454D1701383Q37000961-41D10B66-20F9-47FB-A9CC-3BBF189605F6Q37059816-746269CE-DACC-4C10-96B3-1E5BC8D24935Q37289558-281EF20E-5200-46BC-B661-79C64ADA239FQ37366417-A63D8313-EE35-41C8-86AB-75953FF395F4Q37455067-BFDBC4AB-2DED-4111-82A6-8C4618E4B3F0Q37481209-3DDC120B-9FB2-43D4-A13C-2ABFD6ED8813Q37845201-1A4DC81B-0CBE-47E3-9E35-D6E81951529AQ38006702-CEAF78EA-1203-4F33-B48C-491F9E8A5532Q38101368-2B2EBF90-0848-4DA4-AFC4-BA999C8EA7DCQ38161380-58714F97-A839-4404-B396-D85C014FDA2DQ38204289-D18206E6-8E15-489B-A7CC-8D26D856FAF7Q38241483-A3B38B31-7B26-45AD-8C12-D44B89A8ADE0Q38724867-BDF09FF9-8A2C-4965-9D3D-77B2BF7CE094Q38945715-DBC9A9A0-6D44-4D3A-BD5F-881DC9884692Q39225727-A2D637DC-FD75-47F0-BD5B-C1E615C5790DQ39524840-5BCF5295-FBD1-4247-8803-C7EF1137F08DQ39670061-AA911B5D-5B25-45EA-BE34-ED39234F1C54Q39711507-9E9DE12E-5BF6-4785-B0A0-4953574D9920Q39820294-E86DF5DD-D4C1-466D-9D0B-3A1EB1FDCC43Q39975103-4BC123AC-49D5-47FB-A343-58859A4F63F0Q40889745-602B2F0A-BA9F-484A-8D3C-46E096F2B464Q41921083-1AFA8146-2795-469D-A7B0-4F1A2654D6DDQ43089947-ED28E4E3-4A09-44AE-9760-3C7C863A3B59Q43976671-A1E1CDD1-8FFB-46B5-B39F-349FDE784A0BQ44710826-8D83EF33-3D5B-4ED5-976C-40E12F73D761Q46004791-90532922-125A-4F0C-B0CE-634F984F0BC1Q46154560-C4193B68-F7B9-4574-B5E3-1B02CDAF826EQ47898316-C2FF3FB8-CFF3-4714-8FF7-F2C0DAE57E57Q48116084-DD412309-750F-4720-A6FF-31AE74695B6AQ48128543-D535CD53-C643-4F17-BED8-DB32C8230F26Q48264439-5E6BCE75-6728-42CB-B4AB-EFB14BFD3EC4
P2860
Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Hypofractionated stereotactic ...... after high-dose radiotherapy?
@en
Hypofractionated stereotactic ...... after high-dose radiotherapy?
@nl
type
label
Hypofractionated stereotactic ...... after high-dose radiotherapy?
@en
Hypofractionated stereotactic ...... after high-dose radiotherapy?
@nl
prefLabel
Hypofractionated stereotactic ...... after high-dose radiotherapy?
@en
Hypofractionated stereotactic ...... after high-dose radiotherapy?
@nl
P2093
P2860
P1476
Hypofractionated stereotactic ...... after high-dose radiotherapy?
@en
P2093
Elitsa Encheva
Emmanouil Fokas
Markus W Gross
Martin Henzel
Rita Engenhart-Cabillic
Ulrich Wacker
P2860
P2888
P304
P356
10.1007/S00066-009-1753-X
P577
2009-04-16T00:00:00Z